$ProShares Ultra纳斯达克生物科 (BIB.US)$was climbing 1.5%. $SciSparc (SPRC.US)$rallied Wednesday, climbing over 20%, after the Israeli pharmaceuticals company said the psychedelic-based MEAI drug candidate developed with Canadian collaborator Clearmind Medicine produced a significant decrease in coccaine craving in rats compared to those in a non-treated control group during pre-clinical testing. $Glaukos (GKOS.US)$gained 6% after We...
ProShares Ultra纳斯达克生物科股票讨论
moomoo.com/cour...
$SciSparc (SPRC.US)$ rallied Wednesday, climbing over 20%, after the Israeli pharmaceuticals company said the psychedelic-based MEAI drug candidate developed with Canadian collaborator Clearmind Medicine produced a significant decrease in coccaine craving in rats compared to those in a non-treated control group during pre-clinical testing.
$Glaukos (GKOS.US)$ gained 6% after We...
暂无评论